Does stem cell transplantation have a role in the management of multiple myeloma, 2009?

被引：0
|
作者：
Gertz, Morie A. [1 ]
Buadi, Francis K. [1 ]
机构：
[1] Mayo Clin, Div Hematol, Rochester, MN 55905 USA
来源：
EXPERT OPINION ON PHARMACOTHERAPY | 2009年 / 10卷 / 01期
关键词：
multiple myeloma; autologous stem cell transplantation; BORTEZOMIB; THERAPY; THALIDOMIDE; CHEMOTHERAPY; SURVIVAL; IMPACT;
D O I：
10.1517/14656560802636839
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：1 / 4
页数：4
相关论文
共 50 条
  • [31] Initial therapy of multiple myeloma in patients who are candidates for stem cell transplantation
    Bensinger W.
    Current Treatment Options in Oncology, 2007, 8 (2) : 135 - 143
  • [32] Clinical Implications of t(11;14) in Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplantation
    Takamatsu, Hiroyuki
    Yamashita, Takeshi
    Kurahashi, Shingo
    Saitoh, Takayuki
    Kondo, Tadakazu
    Maeda, Takeshi
    Nakazawa, Hideyuki
    Murata, Makoto
    Narita, Tomoko
    Kuroda, Junya
    Hashimoto, Hisako
    Kawamura, Koji
    Miyamoto, Toshihiro
    Honda, Sumihisa
    Ichinohe, Tatsuo
    Atsuta, Yoshiko
    Sunami, Kazutaka
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (03) : 474 - 479
  • [33] Autologous stem cell transplantation in multiple myeloma
    Ricciuti, Giuseppina
    Falcone, Antonietta
    Cascavilla, Nicola
    Martinelli, Giovanni
    Cerchione, Claudio
    PANMINERVA MEDICA, 2020, 62 (04) : 220 - 224
  • [34] Stem-cell transplantation in multiple myeloma
    Harousseau, JL
    Moreau, P
    Attal, M
    Facon, T
    Avet-Loiseau, H
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2005, 18 (04) : 603 - 618
  • [35] HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR MULTIPLE MYELOMA
    Koniarczyk, Heather L.
    Ferraro, Christina
    Miceli, Teresa
    SEMINARS IN ONCOLOGY NURSING, 2017, 33 (03) : 265 - 278
  • [36] Current Role of Allogeneic Stem Cell Transplantation in Multiple Myeloma
    Jean-Sébastien Claveau
    Francis K. Buadi
    Shaji Kumar
    Oncology and Therapy, 2022, 10 : 105 - 122
  • [37] Current Role of Allogeneic Stem Cell Transplantation in Multiple Myeloma
    Claveau, Jean-Sebastien
    Buadi, Francis K.
    Kumar, Shaji
    ONCOLOGY AND THERAPY, 2022, 10 (01) : 105 - 122
  • [38] Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed Multiple Myeloma
    Efebera, Yvonne A.
    Qureshi, Sofia R.
    Cole, Suzanne M.
    Saliba, Rima
    Pelosini, Matteo
    Patel, Ronak M.
    Koca, Ebru
    Mendoza, Floralyn L.
    Wang, Michael
    Shah, Jatin
    Alousi, Amin
    Hosing, Chitra
    Popat, Uday
    Kebriaei, Partow
    Anderlini, Paolo
    Khouri, Issa F.
    Champlin, Richard
    Giralt, Sergio
    Qazilbash, Muzaffar H.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2010, 16 (08) : 1122 - 1129
  • [39] Long-term outcomes after autologous stem cell transplantation for multiple myeloma
    Nishimura, Katherine K.
    Barlogie, Bart
    van Rhee, Frits
    Zangari, Maurizio
    Walker, Brian A.
    Rosenthal, Adam
    Schinke, Carolina
    Thanendrarajan, Sharmilan
    Davies, Faith E.
    Hoering, Antje
    Morgan, Gareth J.
    BLOOD ADVANCES, 2020, 4 (02) : 422 - 431
  • [40] Autologous stem cell transplantation in first remission is associated with better progression-free survival in multiple myeloma
    Aggarwal, Mukul
    Agrawa, Narendra
    Yadav, Neha
    Verma, Priyanka
    Ahmed, Rayaz
    Mehta, Pallavi
    Kapoor, Jyotsna
    Bhurani, Dinesh
    ANNALS OF HEMATOLOGY, 2018, 97 (10) : 1869 - 1877
12345